4.7 Article

Activation of GPR120 in podocytes ameliorates kidney fibrosis and inflammation in diabetic nephropathy

Journal

ACTA PHARMACOLOGICA SINICA
Volume 42, Issue 2, Pages 252-263

Publisher

NATURE PUBL GROUP
DOI: 10.1038/s41401-020-00520-4

Keywords

diabetic nephropathy; GPR120; TUG-891; db; dbmice; MPC5 podocyte; fibrosis; inflammation

Funding

  1. National Key Research and Development Program [2016YFC1305403]
  2. 135 Project for Disciplines of Excellence from West China Hospital of Sichuan University

Ask authors/readers for more resources

Activation of GPR120 in podocytes plays a crucial role in ameliorating renal inflammation and fibrosis to protect against DN.
Diabetic nephropathy (DN) is one of the most common causes of end-stage renal disease worldwide. omega 3-Fatty acids (omega 3FAs) were found to attenuate kidney inflammation, glomerulosclerosis, and albuminuria in experimental and clinical studies of DN. As G protein-coupled receptor 120 (GPR120) was firstly identified as the receptor of omega 3FAs, we here investigated the function of GPR120 in DN. We first examined the renal biopsies of DN patients, and found that GPR120 expression was negatively correlated with the progression of DN. Immunofluorescence staining analysis revealed that GPR120 protein was mainly located in the podocytes of the glomerulus. A potent and selective GPR120 agonist TUG-891 (35 mg center dot kg(-1) center dot d(-1), ig) was administered todb/dbmice for 4 weeks. We showed that TUG-891 administration significantly improved urinary albumin excretion, protected against podocyte injury, and reduced collagen deposition in the glomerulus. Indb/dbmice, TUG-891 administration significantly inhibited the mRNA and protein expression of fibronectin, collagen IV, alpha-SMA, TGF-beta 1, and IL-6, and downregulated the phosphorylation of Smad3 and STAT3 to alleviate glomerulosclerosis. Similar results were observed in high-glucose-treated MPC5 podocytes in the presence of TUG-891 (10 mu M). Furthermore, we showed that TUG-891 effectively upregulated GPR120 expression, and suppressed TAK1-binding protein-1 expression as well as the phosphorylation of TAK1, IKK beta, NF-kappa B p65, JNK, and p38 MAPK indb/dbmice and high-glucose-treated MPC5 podocytes. Knockdown of GPR120 in MPC5 podocytes caused the opposite effects of TUG-891. In summary, our results highlight that activation of GPR120 in podocytes ameliorates renal inflammation and fibrosis to protect against DN.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available